Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • India likely to impose...

    India likely to impose Anti-dumping duty on pharma industry chemical

    Written by savita thakur thakur Published On 2016-04-25T10:33:30+05:30  |  Updated On 25 April 2016 10:33 AM IST
    India likely to impose Anti-dumping duty on pharma industry chemical

    New Delhi : India is likely to impose anti-dumping duty of up to $279.78 per tonne on imports of a chemical used by pharma, agro and fragrance industries from China and Russia to protect domestic manufacturers.


    Gujarat Fluorochemicals and Chemplast Sanmar had moved the Directorate General of Anti-Dumping and Allied Duties (DGAD) for imposition of the duty alleging dumping of the chemical from these two countries.

    DGAD has recommended to the revenue department to impose the levy ranging between $122.14 and $279.78 per tonne on the imports of 'Methylene Chloride'.

    "having established positive dumping margins as well as material injury to the domestic industry caused by such dumped imports, the Authority (DGAD) is of the view that imposition of duty is required to offset dumping causing injury," DGAD said in notification while recommending the levy.

    In April last year, it had initiated a probe into the alleged dumping, and injury to the domestic industry.

    The product is used in the manufacturing of rayon yarn, pharmaceuticals, agro and fragrance. It is also used as an extractant for edible fats, cocoa, butter and essences.

    The purpose of anti-dumping duties is to eliminate injury caused to the domestic industry by unfair trade practices like dumping pricing goods below their cost for export markets. The step is intended to re-establish open and fair competition in the market.

    Imposition of the duties might affect price levels of the downstream products and consequently might have some influence on relative competitiveness of these products.
    Anti-DumpingDGADDirectorate General of Anti-Dumping and Allied DutiesPharma Industry
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok